顶部logo
顶部logo
more_1

home

ホーム > レポート一覧 > グローバル遺伝子治療市場規模、主要企業シェア、ランキング分析レポート【2026年版】

グローバル遺伝子治療市場規模、主要企業シェア、ランキング分析レポート【2026年版】

Gene Therapy - Global Top Players Market Share and Ranking 2026
  • レポートID：
    48223
  • 発表時期：
    2026-01-07
  • レポート形式：
    PDF
  • 産業カテゴリー：
    医療関係技術およびそのサービス
  • レポート言語：
    英語、日本語
  • ページ数：
    116
  • 発行会社（調査会社）：
    YHResearch
title

言語とエディションの価格

  • 英語版
  • 日本語版
  • 英語と日本語版

個人版詳細

マルチユーザー版詳細

企業版詳細

  • 英語版
  • 日本語版
  • 英語と日本語版

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.40円。

※米ドル表示価格+10％消費税。

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

title

レポートの概要

本レポートは、グローバル遺伝子治療市場の現状および将来動向を多角的に分析し、製品別、用途別、企業別、地域別・国別などの視点から市場規模と成長性を明確化しています。遺伝子治療市場シェアおよび前年比成長率を定量的に整理し、市場全体の構造と中長期的な成長ポテンシャルを把握できる内容となっています。
また、遺伝子治療市場における競争環境の理解を深めるため、主要企業の事業概要、売上および企業ランキングを収録しています。加えて、業界を牽引する技術動向や新製品開発の最新トレンドについても体系的に解説し、戦略立案や市場参入判断に有用な情報を提供しています。
 世界遺伝子治療市場規模および将来展望
・2025年の市場規模：15240百万米ドル
・2026年の市場規模：19030百万米ドル
・2032年までに75800百万米ドル規模に達すると予測されております。
また、2026年から2032年にかけての年平均成長率（CAGR）は25.9%と想定されています。
遺伝子治療市場構造を包括的に把握するため、競争環境や主要企業の事業概要を体系的に整理し、市場シェアに基づく企業ランキングを収録しています。同時に、業界の発展に影響を与える技術動向や新製品開発の動向についても体系的な分析を行っております。 
◆ 遺伝子治療市場区分
企業別
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Roche
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
CSL Behring
BioMarin Pharmaceutical 

製品別
Viral Gene Therapy
Non-Viral Gene Therapy 

アプリケーション別
Neurological Diseases
Cancer
Other 

地域別
　- 北米（米国、カナダ、メキシコ）
　- ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア、その他のヨーロッパ地域）
　- アジア太平洋（中国、日本、韓国、インド、東南アジア、オーストラリア、その他のアジア太平洋地域）
　- 南米（ブラジル、その他の南米地域）
　- 中東・アフリカ

目次
第1章　市場概要
遺伝子治療市場の定義、市場規模、成長見通しを提示し、世界市場および日本市場における売上の推移を整理します。同時に、主要な市場課題と成長機会について包括的な分析を行います
第2章　世界市場における主要企業の競争分析
遺伝子治療業界をリードする主要企業について、市場シェア、企業ランキング、売上、成長戦略を分析し、企業別の競争ポジションを明確化します
第3章　日本市場の競争構造および市場動向
日本遺伝子治療市場における主要企業の売上、市場シェアを分析し、国内市場特有の成長要因および政策・制度の影響を整理します
第4章　サプライチェーン構造と産業バリューチェーン分析
原材料調達から製造、流通、最終用途に至る遺伝子治療産業チェーンを整理し、各段階が市場形成に与える影響を分析します
第5章　製品別市場分析
遺伝子治療を製品別に分類し、売上、市場シェア、CAGRの推移および競争環境を体系的に分析します
第6章　アプリケーション別需要動向分析
アプリケーション別の遺伝子治療導入状況、需要構造の変化、用途別市場シェアおよび主要応用分野の成長見通しを提示します
第7章　地域別市場分析と成長見通し
北米、欧州、アジア太平洋、南米、中東・アフリカを対象に、地域別の遺伝子治療市場規模、成長率および市場課題を分析します
第8章　主要国別市場分析
米国、中国、日本、韓国など主要国を中心に、遺伝子治療の売上、消費量、CAGRを国別に詳細に整理します
第9章　主要企業プロファイルおよび戦略分析
遺伝子治療市場における代表的企業について、企業概要、製品ポートフォリオ、事業展開、売上規模、収益性指標を基に競争力を評価します
第10章　調査結果の総括
遺伝子治療市場分析に基づく主な結論と将来の業界トレンドのまとめです
第11章　付録（調査手法、データソース）
研究方法論、データソースなどの詳細情報を掲載しております

本レポートのメリット
（1）市場規模と成長トレンドの把握
世界の遺伝子治療市場について、過去実績（2021～2025年）と将来予測（2026～2032年）のデータを基に、市場規模および成長トレンドを体系的に分析しています。中長期的な市場の方向性を把握することで、戦略立案や投資判断を的確に支援します
（2）主要企業の競争力評価
世界遺伝子治療市場における主要企業の売上、市場シェア、企業ランキングを整理し、競争構造を明確化しています。各社の市場ポジションを把握することで、競争優位性強化に向けた戦略検討に活用できます
（3）日本市場に特化した戦略的インサイト
日本遺伝子治療市場を対象に、主要企業の売上、市場シェア、ランキングを詳細に分析しています。日本市場特有の構造や動向を踏まえた情報により、効果的な市場参入戦略や事業拡大施策の検討が可能となります
（4）消費地域別の需要構造分析
世界主要地域における遺伝子治療の消費動向と需要構造を分析し、地域別の市場特性を明らかにしています。ターゲット市場の選定や地域別マーケティング戦略の最適化に有効な参考情報を提供します
（5）産業チェーン全体の影響分析
遺伝子治療産業における上流（原材料）、中流（製造）、下流（流通・用途）の各段階を分析し、市場全体への影響を明確にしています。自社のポジショニングを客観的に把握し、事業戦略の見直しや強化に役立てることができます
title

Description

According to YH Research, the global market for Gene Therapy should grow from US$ 15240 million in 2025 to US$ 75800 million by 2032, with a CAGR of 25.9% for the period of 2026-2032.

Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.
The Gene Therapy market is driven by the growing demand for innovative treatments for rare genetic disorders, cancers, and chronic diseases that lack effective conventional therapies. Advancements in gene editing technologies such as CRISPR/Cas9, improved viral and non-viral delivery vectors, and increasing knowledge of the human genome have made gene therapy a promising option in precision medicine. Regulatory agencies are also offering accelerated approval pathways for breakthrough gene therapies, encouraging investment and speeding up clinical development. In addition, rising public and private funding, along with successful commercialization of landmark therapies like Zolgensma and Luxturna, are fueling confidence and expansion in this market.

Despite its potential, the Gene Therapy market faces several critical challenges, including high development and treatment costs, complex manufacturing processes, and safety concerns. Producing gene therapies requires highly specialized facilities and stringent quality control, leading to limited scalability and high prices, which can exceed millions of dollars per patient. Furthermore, long-term safety data are still lacking, with concerns over immune responses, off-target effects, and durability of treatment outcomes. Regulatory, ethical, and reimbursement hurdles also pose significant barriers to broader adoption. Addressing these challenges is essential to ensure accessibility, affordability, and the long-term success of gene therapy as a mainstream medical solution.

Global Gene Therapy key players include Biogen, Novartis, Gilead Sciences, etc. Global top three manufacturers hold a share about 75%. North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, both have a share about 35 percent.  In terms of product, Non-viral Gene Therapy is the largest segment, with a share about 55%. And in terms of application, the largest application is Neurological Diseases, followed by Cancer.

This report studies and analyses global Gene Therapy status and future trends, to help determine the Gene Therapy market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Gene Therapy, and provides market size (US$ million) and Year-over-Year growth, considering 2025 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Gene Therapy market size, history data 2021-2025, and forecast data 2026 -2032, (US$ million)
(2) Global Gene Therapy by company, revenue, market share and industry ranking 2021-2026, (US$ million)
(3) Japan Gene Therapy by company, revenue, market share and industry ranking 2021-2026, (US$ million)
(4) Global Gene Therapy key consuming regions, consumption value and demand structure
(5) Gene Therapy industry chains, upstream, midstream and downstream
Market segment by players, this report covers
    Biogen
    Novartis
    Gilead Sciences
    Sarepta Therapeutics
    Alnylam Pharmaceuticals
    Amgen
    Roche
    Akcea Therapeutics
    bluebird bio
    Sunway Biotech
    SIBIONO
    AnGes
    Orchard Therapeutics
    Human Stem Cells Institute
    CSL Behring
    BioMarin Pharmaceutical

Market segment by Type, covers
    Viral Gene Therapy
    Non-Viral Gene Therapy

Market segment by Application, can be divided into
    Neurological Diseases
    Cancer
    Other

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Gene Therapy product scope, global consumption value, Japan consumption value, development opportunities, challenges, trends, and policies
Chapter 2: Global Gene Therapy market share and ranking of major manufacturers, revenue, 2021-2026
Chapter 3: Japan Gene Therapy market share and ranking of major manufacturers, revenue, 2021-2026
Chapter 4: Gene Therapy industry chain, upstream, medium-stream, and downstream
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2021-2032
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2021-2032
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2021-2032
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2021-2032
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin
Chapter 10: Conclusions
title

Table of Contents

1 Market Overview
    1.1 Gene Therapy Definition
    1.2 Global Gene Therapy Market Size and Forecast
    1.3 Japan Gene Therapy Market Size and Forecast
    1.4 Share of Japan Gene Therapy Market with Respect to the Global Market
    1.5 Gene Therapy Market Size: Japan VS Global Growth Rate, 2021-2032
    1.6 Gene Therapy Market Dynamics
        1.6.1 Gene Therapy Market Drivers
        1.6.2 Gene Therapy Market Restraints
        1.6.3 Gene Therapy Industry Trends
        1.6.4 Gene Therapy Industry Policy
2 Global Leading Players and Market Share
    2.1 By Revenue of Gene Therapy, Global Market Share by Company, 2021-2026
    2.2 Global Gene Therapy Participants, Market Position (Tier 1, Tier 2, and Tier 3)
    2.3 Global Gene Therapy Concentration Ratio
    2.4 Global Gene Therapy Mergers & Acquisitions, Expansion Plans
    2.5 Global Gene Therapy Major Companies Product Type
    2.6 Head Office and Area Served of Key Players
3 Japan Leading Players, Market Share and Ranking
    3.1 By Revenue of Gene Therapy, Japan Market Share by Company, 2021-2026
    3.2 Japan Gene Therapy Gene Therapy Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
    4.1 Gene Therapy Industry Chain
    4.2 Gene Therapy Upstream Analysis
        4.2.1 Gene Therapy Core Raw Materials
        4.2.2 Main Manufacturers of Gene Therapy Core Raw Materials
    4.3 Midstream Analysis
    4.4 Downstream Analysis
    4.5 Gene Therapy Production Mode
    4.6 Gene Therapy Procurement Model
    4.7 Gene Therapy Industry Sales Model and Sales Channels
        4.7.1 Gene Therapy Sales Model
        4.7.2 Gene Therapy Typical Distributors
5 Sights by Type
    5.1 Gene Therapy Classification by Type
        5.1.1 Viral Gene Therapy
        5.1.2 Non-Viral Gene Therapy
    5.2 by Type, Global Gene Therapy Consumption Value & CAGR, 2021 VS 2025 VS 2032
    5.3 by Type, Global Gene Therapy Consumption Value, 2021-2032
6 Sights by Application
    6.1 Gene Therapy Segment by Application
        6.1.1 Neurological Diseases
        6.1.2 Cancer
        6.1.3 Other
    6.2 by Application, Global Gene Therapy Consumption Value & CAGR, 2021 VS 2025 VS 2032
    6.3 by Application, Global Gene Therapy Consumption Value, 2021-2032
7 Sales Sights by Region
    7.1 By Region, Global Gene Therapy Consumption Value, 2021 VS 2025 VS 2032
    7.2 By Region, Global Gene Therapy Consumption Value, 2021-2032
    7.3 North America
        7.3.1 North America Gene Therapy Market Size & Forecasts, 2021-2032
        7.3.2 By Country, North America Gene Therapy Market Size Market Share
    7.4 Europe
        7.4.1 Europe Gene Therapy Market Size & Forecasts, 2021-2032
        7.4.2 By Country, Europe Gene Therapy Market Size Market Share
    7.5 Asia Pacific
        7.5.1 Asia Pacific Gene Therapy Market Size & Forecasts, 2021-2032
        7.5.2 By Country/Region, Asia Pacific Gene Therapy Market Size Market Share
    7.6 South America
        7.6.1 South AmericaGene Therapy Market Size & Forecasts, 2021-2032
        7.6.2 By Country, South America Gene Therapy Market Size Market Share
    7.7 Middle East & Africa
8 Sales Sights by Country Level
    8.1 By Country, Global Gene Therapy Market Size & CAGR, 2021 VS 2025 VS 2032
    8.2 By Country, Global Gene Therapy Consumption Value, 2021-2032
    8.3 United States
        8.3.1 United States Gene Therapy Market Size, 2021-2032
        8.3.2 by Type, United States Gene Therapy Consumption Value Market Share, 2025 VS 2032
        8.3.3 by Application, United States Gene Therapy Consumption Value Market Share, 2025 VS 2032
    8.4 Europe
        8.4.1 Europe Gene Therapy Market Size, 2021-2032
        8.4.2 by Type, Europe Gene Therapy Consumption Value Market Share, 2025 VS 2032
        8.4.3 by Application, Europe Gene Therapy Consumption Value Market Share, 2025 VS 2032
    8.5 China
        8.5.1 China Gene Therapy Market Size, 2021-2032
        8.5.2 by Type, China Gene Therapy Consumption Value Market Share, 2025 VS 2032
        8.5.3 by Application, China Gene Therapy Consumption Value Market Share, 2025 VS 2032
    8.6 Japan
        8.6.1 Japan Gene Therapy Market Size, 2021-2032
        8.6.2 by Type, Japan Gene Therapy Consumption Value Market Share, 2025 VS 2032
        8.6.3 by Application, Japan Gene Therapy Consumption Value Market Share, 2025 VS 2032
    8.7 South Korea
        8.7.1 South Korea Gene Therapy Market Size, 2021-2032
        8.7.2 by Type, South Korea Gene Therapy Consumption Value Market Share, 2025 VS 2032
        8.7.3 by Application, South Korea Gene Therapy Consumption Value Market Share, 2025 VS 2032
    8.8 Southeast Asia
        8.8.1 Southeast Asia Gene Therapy Market Size, 2021-2032
        8.8.2 by Type, Southeast Asia Gene Therapy Consumption Value Market Share, 2025 VS 2032
        8.8.3 by Application, Southeast Asia Gene Therapy Consumption Value Market Share, 2025 VS 2032
    8.9 India
        8.9.1 India Gene Therapy Market Size, 2021-2032
        8.9.2 by Type, India Gene Therapy Consumption Value Market Share, 2025 VS 2032
        8.9.3 by Application, India Gene Therapy Consumption Value Market Share, 2025 VS 2032
    8.10 Middle East & Africa
        8.10.1 Middle East & Africa Gene Therapy Market Size, 2021-2032
        8.10.2 by Type, Middle East & Africa Gene Therapy Consumption Value Market Share, 2025 VS 2032
        8.10.3 by Application, Middle East & Africa Gene Therapy Consumption Value Market Share, 2025 VS 2032
9 Company Profile
    9.1 Biogen
        9.1.1 Biogen Company Information, Head Office, Market Area, and Industry Position
        9.1.2 Biogen Company Profile and Main Business
        9.1.3 Biogen Gene Therapy Models, Specifications, and Application
        9.1.4 Biogen Gene Therapy Revenue and Gross Margin, 2021-2026
        9.1.5 Biogen Recent Developments
    9.2 Novartis
        9.2.1 Novartis Company Information, Head Office, Market Area, and Industry Position
        9.2.2 Novartis Company Profile and Main Business
        9.2.3 Novartis Gene Therapy Models, Specifications, and Application
        9.2.4 Novartis Gene Therapy Revenue and Gross Margin, 2021-2026
        9.2.5 Novartis Recent Developments
    9.3 Gilead Sciences
        9.3.1 Gilead Sciences Company Information, Head Office, Market Area, and Industry Position
        9.3.2 Gilead Sciences Company Profile and Main Business
        9.3.3 Gilead Sciences Gene Therapy Models, Specifications, and Application
        9.3.4 Gilead Sciences Gene Therapy Revenue and Gross Margin, 2021-2026
        9.3.5 Gilead Sciences Recent Developments
    9.4 Sarepta Therapeutics
        9.4.1 Sarepta Therapeutics Company Information, Head Office, Market Area, and Industry Position
        9.4.2 Sarepta Therapeutics Company Profile and Main Business
        9.4.3 Sarepta Therapeutics Gene Therapy Models, Specifications, and Application
        9.4.4 Sarepta Therapeutics Gene Therapy Revenue and Gross Margin, 2021-2026
        9.4.5 Sarepta Therapeutics Recent Developments
    9.5 Alnylam Pharmaceuticals
        9.5.1 Alnylam Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
        9.5.2 Alnylam Pharmaceuticals Company Profile and Main Business
        9.5.3 Alnylam Pharmaceuticals Gene Therapy Models, Specifications, and Application
        9.5.4 Alnylam Pharmaceuticals Gene Therapy Revenue and Gross Margin, 2021-2026
        9.5.5 Alnylam Pharmaceuticals Recent Developments
    9.6 Amgen
        9.6.1 Amgen Company Information, Head Office, Market Area, and Industry Position
        9.6.2 Amgen Company Profile and Main Business
        9.6.3 Amgen Gene Therapy Models, Specifications, and Application
        9.6.4 Amgen Gene Therapy Revenue and Gross Margin, 2021-2026
        9.6.5 Amgen Recent Developments
    9.7 Roche
        9.7.1 Roche Company Information, Head Office, Market Area, and Industry Position
        9.7.2 Roche Company Profile and Main Business
        9.7.3 Roche Gene Therapy Models, Specifications, and Application
        9.7.4 Roche Gene Therapy Revenue and Gross Margin, 2021-2026
        9.7.5 Roche Recent Developments
    9.8 Akcea Therapeutics
        9.8.1 Akcea Therapeutics Company Information, Head Office, Market Area, and Industry Position
        9.8.2 Akcea Therapeutics Company Profile and Main Business
        9.8.3 Akcea Therapeutics Gene Therapy Models, Specifications, and Application
        9.8.4 Akcea Therapeutics Gene Therapy Revenue and Gross Margin, 2021-2026
        9.8.5 Akcea Therapeutics Recent Developments
    9.9 bluebird bio
        9.9.1 bluebird bio Company Information, Head Office, Market Area, and Industry Position
        9.9.2 bluebird bio Company Profile and Main Business
        9.9.3 bluebird bio Gene Therapy Models, Specifications, and Application
        9.9.4 bluebird bio Gene Therapy Revenue and Gross Margin, 2021-2026
        9.9.5 bluebird bio Recent Developments
    9.10 Sunway Biotech
        9.10.1 Sunway Biotech Company Information, Head Office, Market Area, and Industry Position
        9.10.2 Sunway Biotech Company Profile and Main Business
        9.10.3 Sunway Biotech Gene Therapy Models, Specifications, and Application
        9.10.4 Sunway Biotech Gene Therapy Revenue and Gross Margin, 2021-2026
        9.10.5 Sunway Biotech Recent Developments
    9.11 SIBIONO
        9.11.1 SIBIONO Company Information, Head Office, Market Area, and Industry Position
        9.11.2 SIBIONO Company Profile and Main Business
        9.11.3 SIBIONO Gene Therapy Models, Specifications, and Application
        9.11.4 SIBIONO Gene Therapy Revenue and Gross Margin, 2021-2026
        9.11.5 SIBIONO Recent Developments
    9.12 AnGes
        9.12.1 AnGes Company Information, Head Office, Market Area, and Industry Position
        9.12.2 AnGes Company Profile and Main Business
        9.12.3 AnGes Gene Therapy Models, Specifications, and Application
        9.12.4 AnGes Gene Therapy Revenue and Gross Margin, 2021-2026
        9.12.5 AnGes Recent Developments
    9.13 Orchard Therapeutics
        9.13.1 Orchard Therapeutics Company Information, Head Office, Market Area, and Industry Position
        9.13.2 Orchard Therapeutics Company Profile and Main Business
        9.13.3 Orchard Therapeutics Gene Therapy Models, Specifications, and Application
        9.13.4 Orchard Therapeutics Gene Therapy Revenue and Gross Margin, 2021-2026
        9.13.5 Orchard Therapeutics Recent Developments
    9.14 Human Stem Cells Institute
        9.14.1 Human Stem Cells Institute Company Information, Head Office, Market Area, and Industry Position
        9.14.2 Human Stem Cells Institute Company Profile and Main Business
        9.14.3 Human Stem Cells Institute Gene Therapy Models, Specifications, and Application
        9.14.4 Human Stem Cells Institute Gene Therapy Revenue and Gross Margin, 2021-2026
        9.14.5 Human Stem Cells Institute Recent Developments
    9.15 CSL Behring
        9.15.1 CSL Behring Company Information, Head Office, Market Area, and Industry Position
        9.15.2 CSL Behring Company Profile and Main Business
        9.15.3 CSL Behring Gene Therapy Models, Specifications, and Application
        9.15.4 CSL Behring Gene Therapy Revenue and Gross Margin, 2021-2026
        9.15.5 CSL Behring Recent Developments
    9.16 BioMarin Pharmaceutical
        9.16.1 BioMarin Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
        9.16.2 BioMarin Pharmaceutical Company Profile and Main Business
        9.16.3 BioMarin Pharmaceutical Gene Therapy Models, Specifications, and Application
        9.16.4 BioMarin Pharmaceutical Gene Therapy Revenue and Gross Margin, 2021-2026
        9.16.5 BioMarin Pharmaceutical Recent Developments
10 Conclusion
11 Appendix
    11.1 Research Methodology
    11.2 Data Source
        11.2.1 Secondary Sources
        11.2.2 Primary Sources
    11.3 Market Estimation Model
    11.4 Disclaimer
title

Table of Figures

List of Tables
 Table 1. Gene Therapy Consumption Value & CAGR: Japan VS Global, 2021-2032, US$ Million
 Table 2. Gene Therapy Market Restraints
 Table 3. Gene Therapy Market Trends
 Table 4. Gene Therapy Industry Policy
 Table 5. Global Gene Therapy Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025
 Table 6. Global Gene Therapy Revenue Share by Company, 2021-2026, Ranked by Data of 2025
 Table 7. Global Gene Therapy Manufacturers Market Concentration Ratio (CR3 and HHI)
 Table 8. Global Gene Therapy Mergers & Acquisitions, Expansion Plans
 Table 9. Global Gene Therapy Major Companies Product Type
 Table 10. Head Office and Area Served of Key Players
 Table 11. Japan Gene Therapy Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025
 Table 12. Japan Gene Therapy Revenue Market Share by Company, 2021-2026
 Table 13. Global Key Players of Gene Therapy Upstream (Raw Materials)
 Table 14. Global Gene Therapy Typical Customers
 Table 15. Gene Therapy Typical Distributors
 Table 16. by Type, Global Gene Therapy Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
 Table 17. by Application, Global Gene Therapy Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
 Table 18. By Region, Global Gene Therapy Consumption Value, 2021 VS 2025 VS 2032, US$ Million
 Table 19. By Region, Global Gene Therapy Consumption Value, 2021-2032, US$ Million
 Table 20. By Country, Global Gene Therapy Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
 Table 21. By Country, Global Gene Therapy Consumption Value, 2021-2032, US$ Million
 Table 22. By Country, Global Gene Therapy Consumption Value Market Share, 2021-2032
 Table 23. Biogen Company Information, Head Office, Market Area, and Industry Position
 Table 24. Biogen Company Profile and Main Business
 Table 25. Biogen Gene Therapy Models, Specifications, and Application
 Table 26. Biogen Gene Therapy Revenue and Gross Margin, US$ Million, 2021-2026
 Table 27. Biogen Recent Developments
 Table 28. Novartis Company Information, Head Office, Market Area, and Industry Position
 Table 29. Novartis Company Profile and Main Business
 Table 30. Novartis Gene Therapy Models, Specifications, and Application
 Table 31. Novartis Gene Therapy Revenue and Gross Margin, US$ Million, 2021-2026
 Table 32. Novartis Recent Developments
 Table 33. Gilead Sciences Company Information, Head Office, Market Area, and Industry Position
 Table 34. Gilead Sciences Company Profile and Main Business
 Table 35. Gilead Sciences Gene Therapy Models, Specifications, and Application
 Table 36. Gilead Sciences Gene Therapy Revenue and Gross Margin, US$ Million, 2021-2026
 Table 37. Gilead Sciences Recent Developments
 Table 38. Sarepta Therapeutics Company Information, Head Office, Market Area, and Industry Position
 Table 39. Sarepta Therapeutics Company Profile and Main Business
 Table 40. Sarepta Therapeutics Gene Therapy Models, Specifications, and Application
 Table 41. Sarepta Therapeutics Gene Therapy Revenue and Gross Margin, US$ Million, 2021-2026
 Table 42. Sarepta Therapeutics Recent Developments
 Table 43. Alnylam Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
 Table 44. Alnylam Pharmaceuticals Company Profile and Main Business
 Table 45. Alnylam Pharmaceuticals Gene Therapy Models, Specifications, and Application
 Table 46. Alnylam Pharmaceuticals Gene Therapy Revenue and Gross Margin, US$ Million, 2021-2026
 Table 47. Alnylam Pharmaceuticals Recent Developments
 Table 48. Amgen Company Information, Head Office, Market Area, and Industry Position
 Table 49. Amgen Company Profile and Main Business
 Table 50. Amgen Gene Therapy Models, Specifications, and Application
 Table 51. Amgen Gene Therapy Revenue and Gross Margin, US$ Million, 2021-2026
 Table 52. Amgen Recent Developments
 Table 53. Roche Company Information, Head Office, Market Area, and Industry Position
 Table 54. Roche Company Profile and Main Business
 Table 55. Roche Gene Therapy Models, Specifications, and Application
 Table 56. Roche Gene Therapy Revenue and Gross Margin, US$ Million, 2021-2026
 Table 57. Roche Recent Developments
 Table 58. Akcea Therapeutics Company Information, Head Office, Market Area, and Industry Position
 Table 59. Akcea Therapeutics Company Profile and Main Business
 Table 60. Akcea Therapeutics Gene Therapy Models, Specifications, and Application
 Table 61. Akcea Therapeutics Gene Therapy Revenue and Gross Margin, US$ Million, 2021-2026
 Table 62. Akcea Therapeutics Recent Developments
 Table 63. bluebird bio Company Information, Head Office, Market Area, and Industry Position
 Table 64. bluebird bio Company Profile and Main Business
 Table 65. bluebird bio Gene Therapy Models, Specifications, and Application
 Table 66. bluebird bio Gene Therapy Revenue and Gross Margin, US$ Million, 2021-2026
 Table 67. bluebird bio Recent Developments
 Table 68. Sunway Biotech Company Information, Head Office, Market Area, and Industry Position
 Table 69. Sunway Biotech Company Profile and Main Business
 Table 70. Sunway Biotech Gene Therapy Models, Specifications, and Application
 Table 71. Sunway Biotech Gene Therapy Revenue and Gross Margin, US$ Million, 2021-2026
 Table 72. Sunway Biotech Recent Developments
 Table 73. SIBIONO Company Information, Head Office, Market Area, and Industry Position
 Table 74. SIBIONO Company Profile and Main Business
 Table 75. SIBIONO Gene Therapy Models, Specifications, and Application
 Table 76. SIBIONO Gene Therapy Revenue and Gross Margin, US$ Million, 2021-2026
 Table 77. SIBIONO Recent Developments
 Table 78. AnGes Company Information, Head Office, Market Area, and Industry Position
 Table 79. AnGes Company Profile and Main Business
 Table 80. AnGes Gene Therapy Models, Specifications, and Application
 Table 81. AnGes Gene Therapy Revenue and Gross Margin, US$ Million, 2021-2026
 Table 82. AnGes Recent Developments
 Table 83. Orchard Therapeutics Company Information, Head Office, Market Area, and Industry Position
 Table 84. Orchard Therapeutics Company Profile and Main Business
 Table 85. Orchard Therapeutics Gene Therapy Models, Specifications, and Application
 Table 86. Orchard Therapeutics Gene Therapy Revenue and Gross Margin, US$ Million, 2021-2026
 Table 87. Orchard Therapeutics Recent Developments
 Table 88. Human Stem Cells Institute Company Information, Head Office, Market Area, and Industry Position
 Table 89. Human Stem Cells Institute Company Profile and Main Business
 Table 90. Human Stem Cells Institute Gene Therapy Models, Specifications, and Application
 Table 91. Human Stem Cells Institute Gene Therapy Revenue and Gross Margin, US$ Million, 2021-2026
 Table 92. Human Stem Cells Institute Recent Developments
 Table 93. CSL Behring Company Information, Head Office, Market Area, and Industry Position
 Table 94. CSL Behring Company Profile and Main Business
 Table 95. CSL Behring Gene Therapy Models, Specifications, and Application
 Table 96. CSL Behring Gene Therapy Revenue and Gross Margin, US$ Million, 2021-2026
 Table 97. CSL Behring Recent Developments
 Table 98. BioMarin Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
 Table 99. BioMarin Pharmaceutical Company Profile and Main Business
 Table 100. BioMarin Pharmaceutical Gene Therapy Models, Specifications, and Application
 Table 101. BioMarin Pharmaceutical Gene Therapy Revenue and Gross Margin, US$ Million, 2021-2026
 Table 102. BioMarin Pharmaceutical Recent Developments


List of Figures
 Figure 1. Gene Therapy Picture
 Figure 2. Global Gene Therapy Consumption Value, (US$ million) & (2021-2032)
 Figure 3. Japan Gene Therapy Consumption Value, (US$ million) & (2021-2032)
 Figure 4. By Consumption Value, Japan Gene Therapy Market Share of Global, 2021-2032
 Figure 5. Global Gene Therapy Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2025
 Figure 6. Japan Gene Therapy Key Participants, Market Share, 2025
 Figure 7. Gene Therapy Industry Chain
 Figure 8. Gene Therapy Procurement Model
 Figure 9. Gene Therapy Sales Model
 Figure 10. Gene Therapy Sales Channels, Direct Sales, and Distribution
 Figure 11. Viral Gene Therapy
 Figure 12. Non-Viral Gene Therapy
 Figure 13. by Type, Global Gene Therapy Consumption Value, 2021-2032, US$ Million
 Figure 14. by Type, Global Gene Therapy Consumption Value Market Share, 2021-2032
 Figure 15. Neurological Diseases
 Figure 16. Cancer
 Figure 17. Other
 Figure 18. by Application, Global Gene Therapy Consumption Value, 2021-2032, US$ Million
 Figure 19. by Application, Global Gene Therapy Revenue Market Share, 2021-2032
 Figure 20. By Region, Global Gene Therapy Consumption Value Market Share, 2021-2032
 Figure 21. North America Gene Therapy Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 22. By Country, North America Gene Therapy Consumption Value Market Share, 2025
 Figure 23. Europe Gene Therapy Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 24. By Country, Europe Gene Therapy Consumption Value Market Share, 2025
 Figure 25. Asia Pacific Gene Therapy Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 26. By Country/Region, Asia Pacific Gene Therapy Consumption Value Market Share, 2025
 Figure 27. South America Gene Therapy Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 28. By Country, South America Gene Therapy Consumption Value Market Share, 2025
 Figure 29. Middle East & Africa Gene Therapy Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 30. United States Gene Therapy Consumption Value, 2021-2032, US$ Million
 Figure 31. by Type, United States Gene Therapy Consumption Value Market Share, 2025 VS 2032
 Figure 32. by Application, United States Gene Therapy Consumption Value Market Share, 2025 VS 2032
 Figure 33. Europe Gene Therapy Consumption Value, 2021-2032, US$ Million
 Figure 34. by Type, Europe Gene Therapy Consumption Value Market Share, 2025 VS 2032
 Figure 35. by Application, Europe Gene Therapy Consumption Value Market Share, 2025 VS 2032
 Figure 36. China Gene Therapy Consumption Value, 2021-2032, US$ Million
 Figure 37. by Type, China Gene Therapy Consumption Value Market Share, 2025 VS 2032
 Figure 38. by Application, China Gene Therapy Consumption Value Market Share, 2025 VS 2032
 Figure 39. Japan Gene Therapy Consumption Value, 2021-2032, US$ Million
 Figure 40. by Type, Japan Gene Therapy Consumption Value Market Share, 2025 VS 2032
 Figure 41. by Application, Japan Gene Therapy Consumption Value Market Share, 2025 VS 2032
 Figure 42. South Korea Gene Therapy Consumption Value, 2021-2032, US$ Million
 Figure 43. by Type, South Korea Gene Therapy Consumption Value Market Share, 2025 VS 2032
 Figure 44. by Application, South Korea Gene Therapy Consumption Value Market Share, 2025 VS 2032
 Figure 45. Southeast Asia Gene Therapy Consumption Value, 2021-2032, US$ Million
 Figure 46. by Type, Southeast Asia Gene Therapy Consumption Value Market Share, 2025 VS 2032
 Figure 47. by Application, Southeast Asia Gene Therapy Consumption Value Market Share, 2025 VS 2032
 Figure 48. India Gene Therapy Consumption Value, 2021-2032, US$ Million
 Figure 49. by Type, India Gene Therapy Consumption Value Market Share, 2025 VS 2032
 Figure 50. by Application, India Gene Therapy Consumption Value Market Share, 2025 VS 2032
 Figure 51. Middle East & Africa Gene Therapy Consumption Value, 2021-2032, US$ Million
 Figure 52. by Type, Middle East & Africa Gene Therapy Consumption Value Market Share, 2025 VS 2032
 Figure 53. by Application, Middle East & Africa Gene Therapy Consumption Value Market Share, 2025 VS 2032
 Figure 54. Research Methodology
 Figure 55. Breakdown of Primary Interviews
 Figure 56. Bottom-up Approaches
 Figure 57. Top-down Approaches

お見積>

サンプルお申込み>

今すぐ購入>

PDFダウンロード>

当社から購入のメリット
  • jiantou

    多言語（英語、日本語）のサンプル提供

  • jiantou

    プロフェッショナルな日本語翻訳を提供

  • jiantou

    請求書、クレジットカードでのお支払いが可能です

  • jiantou

    必要なチャプターやカスタマイズされたレポートの注文が可能

  • jiantou

    購入後、アナリストに直接連絡することができます

購入方法
shunxu

  • 必要な言語とバージョンのレポート選択

  • レポート要件と見積もり依頼

  • 電子メールによる注文

  • レポートの入手（英語版は2～4営業日、日本語版は8～10営業日）

  • クレジットカード決済、オフライン振込に対応（後払い可）

※当サイトに掲載されていない海外調査報告書も当社経由でご購入いただけますので、お問い合わせください。

※市場調査レポートの購入や市場調査をご希望の場合は、実績と信頼のある株式会社市場調査センターにお任せください。

*フォーチュン500企業は当社と緊密な協力関係を確立しています

クライアント様（例）
ご利用ガイド
利用規約よくあるご質問プライバシーポリシー支払い方法と購入ガイド
お電話でのお問い合わせ
email050-5840-2692 日本
email0081-50-5840-2692 グローバル
9:00-18:00 (土日・祝日を除く)
底部logo
Copyright 2016-2026 Global Reports著作権所有